Amanote Research
Register
Sign In
Censoring of Prescribable Doses: The Case of Risperidone Long-Acting Injection
Acta Neuropsychiatrica
- United Kingdom
doi 10.1017/s0924270800031392
Full Text
Open PDF
Abstract
Available in
full text
Categories
Psychiatry
Mental Health
Biological Psychiatry
Date
December 1, 2006
Authors
T Lambert
Publisher
Cambridge University Press (CUP)
Related search
Resting Tremor Due to Risperidone Long-Acting Injection
Journal of Neurology Research
The Influence of Switching From Oral Risperidone to Risperidone Long-Acting Injection on the Clinical Symptoms and Cognitive Function in Schizophrenia
Therapeutic Advances in Psychopharmacology
Treatment-Completion Rates With Olanzapine Long-Acting Injection Versus Risperidone Long-Acting Injection in a 12-Month, Open-Label Treatment of Schizophrenia: Indirect, Exploratory Comparisons
International Journal of General Medicine
Medicine
Effects of Continuing Oral Risperidone vs. Switching From Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
Frontiers in Psychiatry
Psychiatry
Mental Health
Patient Perspectives on Use of Long-Acting Antipsychotics in Bipolar Disorder: Focus on Risperidone Injection
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
182 Unintentional Overdose on Long-Acting Injectable Risperidone
CNS Spectrums
Psychiatry
Mental Health
Neurology
Modeling the Choice Between Risperidone Long-Acting Injectable and Generic Risperidone From the Perspective of a Japanese Hospital
Neurology and Therapy
Neurology
Long-Term Clinical Outcome of Patients Using Risperidone Long-Acting Injectable: The Romanian E-Star Database
Open Journal of Psychiatry
Treatment Cost Comparison: Paliperidone Palmitate Versus Risperidone Long Acting in Brazil
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
